1. Haidinger G, Temml C, Schatzl G, Brossner C, Roehlich M, Schmidbauer CP, Madersbacher S. Risk factors for lower urinary tract symptoms in elderly men: for the Prostate Study Group of the Austrian Society of Urology. Eur Urol 2000;37:413-420.
2. Krogh J, Jensen JS, Iversen HG, Andersen JT. Age as a prognostic variable in patients undergoing transurethral prostatectomy. Scand J Urol Nephrol 1993;27:225-229.
5. Sohn HC. Diagnosis of benign prostate hyperplasia. Korean Continence Society. Textbook of voiding difficulty and female urology. 3rd ed. Seoul: Korean Continence Society; 2015. p. 413-422.
6. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 1979;121:640-642.
7. Nielsen KK. Changes in morphology, function and blood flow in mini-pig urinary bladder after chronic outflow obstruction and recovery from obstruction. Scand J Urol Nephrol Suppl 1997;195:1-39.
8. Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008;20:Suppl 3. S11-S18.
9. Hong SJ. Benign prostatic hyperplasia: multiple factors for prostate tissue change with aging. Korean J Urol 2005;46:547-554.
10. O'Leary MP. Tamsulosin: current clinical experience. Urology 2001;58:6 Suppl 1. 42-48.
11. Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003;61:267-273.
12. Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Clinical and biological characteristics of familial benign prostatic hyperplasia. J Urol 1997;157:876-879.
13. Park CH. General management, watchful waiting and medica-tion of benign prostate hyperplasia. Korean Continence Society. Textbook of voiding difficulty and female urology. 3rd ed. Korean Continence Society; 2015. p. 423-433.
14. Lee SH. Surgical treatment of benign prostate hyperplasia.. Korean Continence Society. Textbook of voiding difficulty and female urology. 3rd ed. Seoul: Korean Continence Society; 2015. p. 434-447.
15. McConell JD, Barry MD, Bruskewitz RC. Benign prostattic hyperplasia: diagnosis and treatment. Clinical practice guide-line. Rockville: Agency for Health Care Policy and Research; 1994.
16. Nudell DM, Cattolica EV. Transurethral prostatectomy: an update. AUA Update Ser 2000;19:34-40.
17. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002;60:305-308.
18. Montorsi F, Naspro R, Suardi N, Colombo R, Salonia A, Cestari A, Guazzoni G, Digirolamo V, Rigatti P. Holmium laser enucleation of the prostate (HoLEP) versus open prostatectomy for prostates >70 g: 2-year follow-up. Eur Urol 2006;2:Suppl 5. 234.
20. Yang HT, Choi NG. Changes and differences of sexual function in patients with benign prostate hyperplasia following transurethral resection of prostate and high energy transurethral microwave thermotherapy. Korean J Urol 2001;42:961-966.
21. Perry MJ, Roodhouse AJ, Gidlow AB, Spicer TG, Ellis BW. Thermo-expandable intraprostatic stents in bladder outlet obstruction: an 8-year study. BJU Int 2002;90:216-223.
22. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H. ACS Prostate Cancer Advisory Committee. ACS Colorectal Cancer Advisory Committee. ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001: testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.